Superbug kills woman resistant to all antibiotics in the U.S.

The woman’s friends tell that she was gets hospitalized in India and gets treated there.

Samples of the infection taken from the wound were sent to the CDC for testing.

“We have a shrinking world”, Randall Todd of the Washoe County, Nevada health department, said as reported by NBC News. Many are looking at it as the beginning of a post-antibiotic era-the outcome of-among other factors-pill popping or the misuse of high-end antibiotics for treatment of common health conditions.

The patient died of septic shock in early September a year ago.

The infection was caused by the Klebsiella pneumonia bacteria, which is found in the normal flora of the mouth, skin, and intestines but become deadly when they enter the bloodstream.

Before returning to the US from India, the woman was hospitalized multiple times, complaining of various symptoms.

The US Centres for Disease Control and Prevention’s antimicrobial testing showed the isolate was resistant to 26 different antibiotics, including all aminoglycosides and polymixins – another class of last-resort antibiotics.

Recently, there’s been more focus on antimicrobial resistance.

From the time the drug went into human trials to when it could hypothetically get on the market, 15 years will have passed, he said.

“In the pre-antibiotic era, people were dead by the time they were 30 because of infections”. Yet, superbugs resistant to antibiotics still remain a global concern.

It was also intermittently resistant to tigecycline, an antibiotic developed specifically to overcome drug-resistant organisms.

The presence of an incurable superbug has experts anxious, since superbugs are still extremely rare in the us, according to a Huffington Post report.

Tests revealed the bacteria contained New Delhi metallo-beta-lactamase (NDM), an enzyme that makes superbugs resistant to many antibiotics.

She was seriously ill when she arrived in a U.S. hospital – her immune system was going into overdrive in an attempt to fight the infection causing inflammation throughout her body. It is highly unlikely to be developed soon.

“It could mean that we could die from common skin infections, from pneumonia, from a range of other diseases that we can now relatively easy fight off”, says Kendall. Medical experts say pharmaceutical majors focus less on research for newer broad spectrum antibiotics as their shelf life is less compared to drugs meant for chronic illnesses. While important to develop new antibiotics, “the efforts are not as strong for helping us use our existing antibiotics intelligently”, he told CBS News.

Critics say that, in Canada, government tracking of worrisome, drug-resistant microbes that sicken, by the government’s own count, an estimated 18,000 Canadians each year is patchy and inefficient, and that more urgently needs to be done to contain and control their spread.